SEC Form 4 · accession 0000899243-16-019401
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles G Phillips III
Director
Period of report
May 4, 2016
Accepted (ET)
May 6, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF1 | $11.39 | May 4, 2016 | A | 21,500 | A | — | May 4, 2026 | Ordinary Shares | 21,500 | 21,500 | D |
Explanation of responses
- F1Options to buy 21,500 ordinary shares will fully vest and become exercisable on May 4, 2017, subject to Mr. Phillips serving as a Director through such date.